Olverembatinib (GZD824) dimesylate
Olverembatinib (GZD824) dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
| Trivial name | HQP1351 dimesylate |
| Catalog Number | S7194 |
| CAS# | 1421783-64-3 |
| Size | 25mg |
| Supplier Page | http://www.selleckchem.com/products/gzd824.html |
| Additional Information | https://file.selleck.cn/downloads/struct/GZD824-chemical-structure-s7194.gif |